These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26685097)

  • 21. Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
    Feng Q; Zak D; Daya R
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):270-6. PubMed ID: 22706493
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy alone for early-stage Hodgkin's lymphoma.
    Straus DJ
    N Engl J Med; 2012 Feb; 366(5):470-1. PubMed ID: 22149920
    [No Abstract]   [Full Text] [Related]  

  • 23. Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab.
    Unal A; Sari I; Deniz K; Ozkan M; Kontas O; Eser B; Cetin M
    Leuk Lymphoma; 2005 Nov; 46(11):1613-7. PubMed ID: 16236615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant.
    Drakos E; Rassidakis GZ; Leventaki V; Cotta CV; Vega F; Medeiros LJ
    Am J Surg Pathol; 2009 Nov; 33(11):1725-31. PubMed ID: 19730363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vanishing bile duct syndrome as a presentation of Hodgkin's lymphoma.
    Fatima I; Mahadevia H; Madhusudhana S; Shrestha A
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38772873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.
    Canellos GP
    J Clin Oncol; 2005 Jul; 23(21):4574-6. PubMed ID: 15837972
    [No Abstract]   [Full Text] [Related]  

  • 27. Hematuria--a rare presentation of Hodgkin lymphoma.
    Dembla V; Walker BN; Elkins SL; Files JC
    Clin Adv Hematol Oncol; 2011 Oct; 9(10):788-90; discussion 791-2. PubMed ID: 22252582
    [No Abstract]   [Full Text] [Related]  

  • 28. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly.
    Stamatoullas A; Brice P; Bouabdallah R; Mareschal S; Camus V; Rahal I; Franchi P; Lanic H; Tilly H
    Br J Haematol; 2015 Jul; 170(2):179-84. PubMed ID: 25891777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin's lymphoma--the great teacher.
    Connors JM
    N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
    [No Abstract]   [Full Text] [Related]  

  • 31. Controversies in the treatment of early-stage Hodgkin's lymphoma.
    Longo DL; Armitage JO
    N Engl J Med; 2015 Apr; 372(17):1667-9. PubMed ID: 25901431
    [No Abstract]   [Full Text] [Related]  

  • 32. Central nervous system Hodgkin lymphoma developing during systemic chemotherapy.
    Burrows SH; Mannari D
    Br J Haematol; 2016 Jan; 172(2):156. PubMed ID: 26455346
    [No Abstract]   [Full Text] [Related]  

  • 33. [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
    Dourthe ME; Simonin M; Rigaud C; Haouy S; Montravers F; Ducou Le Pointe H; Garnier N; Minard-Colin V; Jo Molina T; Boudjemaa S; Leblanc T; Landman-Parker J
    Bull Cancer; 2023 Sep; 110(9):968-977. PubMed ID: 37062647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
    Diehl V
    J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791
    [No Abstract]   [Full Text] [Related]  

  • 35. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
    Williamson PJ; de Berker D
    Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077
    [No Abstract]   [Full Text] [Related]  

  • 36. Marathon running during chemotherapy: where are the limits?
    Dimeo FC
    Onkologie; 2011; 34(5):230. PubMed ID: 21577027
    [No Abstract]   [Full Text] [Related]  

  • 37. Marathon run under chemotherapy: is it possible?
    Bernhörster M; Rosenhagen A; Vogt L; Thiel C; Jäger E; Banzer W
    Onkologie; 2011; 34(5):259-61. PubMed ID: 21577032
    [No Abstract]   [Full Text] [Related]  

  • 38. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG; Chandra A; Raman SG
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract]   [Full Text] [Related]  

  • 39. Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
    Borchmann P
    Hematol Oncol Clin North Am; 2014 Feb; 28(1):65-74. PubMed ID: 24287068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the German Hodgkin Study Group].
    Frerker B; Hildebrandt G
    Strahlenther Onkol; 2020 May; 196(5):488-491. PubMed ID: 32170351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.